In light of the potential application of soluble ACE2 in clinical treatment of COVID-19,27,30 our initial goal was to identify residue-positions in ACE2 at which amino acid substitutions could result in enhanced binding to SARS-CoV-2 S-RBD. The gene discussed is ACE2; the disease is COVID-19.